dual agonist glp-1 glucagon GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes The Emerging Role of Dual

Studies and clinical trials have shown that people who take these medications may lose up to 15% of their body weight if combined with a healthy diet and exercise

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a doubleblind, randomised placebocontrolled trial

Those services can range from Botox injections to hormone therapy and compounded weight-loss drugs, like GLP-1 products

10.1371/journal.pone.0173515 [DOI] [PMC free article] [PubMed] [Google Scholar] 6

Patients with predictable responder profiles often achieve weight loss goals 3050% faster than trial-and-error approaches

[1] ^ Joslin's Diabetes Mellitus